TIN2 and TRF1 tended to be more weakly expressed in advanced NSCLC cases (68.2 vs. 218.7; p = 0.054 and 49.5 vs. 177.6; p = 0.070, respectively). Here, TINF2 is linked to non-small cell lung carcinoma.